Adapthealth Corp

Adapthealth Corp

AHCO · NASDAQ · Healthcare / Medical Devices

7.66USD-0.21 (-2.67%)

Price History

Full chart

Market Stats

Previous Close7.87
Open7.87
Day Range7.61 – 7.96
52-Week Range5.21 – 13.43
Volume2.19M
Market Cap757.82M
P/E (TTM)0.00
Forward P/E7.78
EPS-1.67
Dividend Yield0.00%
Beta1.39
50-Day Avg7.14
200-Day Avg9.74

About

AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments. The company offers sleep therapy equipment, supplies, and related services, such as continuous positive airway pressure and BiLevel services to individuals suffering from obstructive sleep apnea; oxygen and home mechanical ventilation equipment and supplies and related chronic therapy services; and medical devices, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; and other HME devices and supplies. It also provides PAP machines, wheelchairs, hospital beds, oxygen concentrators, ventilators, insulin pumps, diabetes management and wound care supplies, orthopedic bracing, breast pumps and supplies, walkers, commodes, enteral supplies, and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. was founded in 2012 and is headquartered in Conshohocken, Pennsylvania.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMs. Suzanne M. Foster M.P.H.
  • Employees10.90K
  • Headquarters555 East North Lane, Conshohocken, PA, United States, 19428, USA
  • Websitehttps://adapthealth.com

Leadership

  • Ms. Suzanne M. Foster M.P.H.CEO & Director · b. 1970
  • Mr. Jason A. Clemens C.F.A.Chief Financial Officer · b. 1979
  • Mr. Albert A. PrastCTO & Chief Innovation Officer · b. 1960
  • Mr. Russell E. Schuster IIIChief Commercial Officer · b. 1977
  • Mr. Daniel McFaddenChief Operations Officer · b. 1971
  • Ms. Christine E. ArchboldChief Accounting Officer · b. 1974
  • Mr. Nalin NarayanamChief Information Officer
  • Ms. Wendy RussalesiChief Compliance Officer
  • Mr. Richard W. Rew IIChief Legal Officer, General Counsel & Secretary · b. 1968
  • Ms. Kelly MorganChief Human Resources Officer

Financials

Income Statement

Currency: USD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue174.32M192.56M345.28M529.64M1.06B2.45B2.97B3.20B3.26B3.24B
Growth (%)-+10.47%+79.31%+53.40%+99.45%+132.35%+21.02%+7.73%+1.90%-0.49%
Cost of Revenue158.69M162.90M285.20M440.70M898.60M2.01B2.55B2.52B2.58B2.68B
Gross Profit15.63M29.66M60.08M88.94M157.79M445.61M417.43M681.77M681.09M568.56M
Gross Margin8.96%15.40%17.40%16.79%14.94%18.15%14.05%21.30%20.89%17.52%
Operating Expense13.30M29.66M61.31M59.56M86.44M220.00M227.01M1.28B417.36M382.29M
Operating Income2.32M-690-1.23M29.38M71.35M225.60M190.41M-598.40M263.73M186.27M
Operating Margin1.33%-0.00%-0.36%5.55%6.75%9.19%6.41%-18.70%8.09%5.74%
EBITDA28.89M-6907.07M80.01M-82.17M544.21M630.76M-171.09M628.02M503.64M
EBITDA Margin16.57%-0.00%2.05%15.11%-7.78%22.17%21.23%-5.35%19.26%15.52%
Net Income-3.79M-6902.09M-21.34M-161.63M156.18M69.32M-678.89M90.42M-70.79M
Net Income Margin-2.18%-0.00%0.60%-4.03%-15.30%6.36%2.33%-21.21%2.77%-2.18%
R&D-310.00K--------
R&D as % of Total Revenue-0.16%--------
Interest Expense004.15M39.30M41.43M95.19M109.41M130.30M126.67M105.75M
Interest Expense % of Total Revenue0.00%0.00%1.20%7.42%3.92%3.88%3.68%4.07%3.88%3.26%

Balance Sheet

Currency: USD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets-310.62K254.12M227.84M1.81B5.25B5.22B4.51B4.49B4.32B
Total Liabilities-286.31K8.57M212.70M1.53B3.18B3.06B3.04B2.91B2.79B
Total Equity-24.31K245.55M15.14M354.89M2.06B2.15B1.46B1.57B1.52B
Cash-119.82K947.10K9.77M99.96M149.63M46.27M77.13M109.75M106.14M
Total Debt-174.24K155.17M397.00M807.00M2.37B2.33B2.29B2.13B1.90B
Net Debt-54.42K154.22M151.60M707.03M2.22B2.28B2.22B2.02B1.80B

Cash Flow

Currency: USD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow29.94M45.93M68.43M60.42M195.63M275.68M373.87M480.67M541.84M601.77M
Investing Cash Flow-2.68M-15.08M-248.87M-84.87M-815.70M-1.82B-411.17M-357.28M-310.27M-303.19M
Financing Cash Flow-27.58M119.82K251.33M-13.89M643.15M1.60B-66.05M-92.53M-198.95M-302.19M
Capital Expenditure2.47M6.85M9.95M21.33M39.76M203.31M391.42M337.46M306.06M382.39M
Free Cash Flow27.47M39.08M58.48M39.09M155.88M72.37M-17.56M143.20M235.78M219.38M
Dividends Paid250.00M250.00M250.00M82.45M935.94M3.56M----
FCF to OCF91.75%85.08%85.46%64.69%79.68%26.25%-4.70%29.79%43.52%36.46%
Dividend Paid to FCF910.19%639.74%427.52%210.95%600.43%4.91%----

Earnings

Report DateJun 30, 2018Nov 8, 2018Mar 29, 2019May 14, 2019Jul 8, 2019Nov 13, 2019Feb 25, 2020May 5, 2020Aug 4, 2020Nov 4, 2020Mar 4, 2021May 6, 2021Aug 5, 2021Nov 4, 2021Feb 24, 2022May 10, 2022Aug 9, 2022Nov 8, 2022Feb 27, 2023May 9, 2023Aug 8, 2023Nov 7, 2023Feb 27, 2024May 7, 2024Aug 6, 2024Nov 5, 2024Feb 25, 2025May 6, 2025Aug 5, 2025Nov 4, 2025Feb 24, 2026May 5, 2026Aug 4, 2026Nov 3, 2026
EPS Estimate----0.000.130.070.080.160.130.170.260.260.390.410.180.330.310.280.140.140.200.180.060.190.180.280.040.160.240.360.01-0.01-0.06
EPS Actual0.020.020.020.030.050.13-0.100.020.160.21-0.690.200.380.370.280.080.200.21-0.020.070.200.21-1.910.150.220.220.420.020.070.230.27-0.050.03-
Surprise-----1.08%-242.86%-75.00%0.00%61.54%-505.88%-23.08%46.15%-5.13%-31.71%-55.56%-39.39%-32.26%-107.14%-50.00%42.86%5.00%-1161.11%150.00%15.79%22.22%49.25%-50.00%-56.25%-4.17%-25.39%-600.00%400.00%-
Timing----After-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap757.82M
Enterprise Value2.78B
Trailing P/E0.00
Forward P/E7.78
Price / Sales0.22
Price / Book0.55
EPS-1.67
Book Value10.34
Revenue (TTM)3.36B
Gross Profit (TTM)644.93M
EBITDA583.47M
Profit Margin-6.79%
Operating Margin0.84%
Return on Equity-15.22%
Return on Assets2.28%
Shares Outstanding136.05M
Shares Float85.77M
Beta1.39
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 8 analystsTarget 9.00
  • Strong Buy
    5
  • Buy
    1
  • Hold
    2

Ownership Breakdown

Institutions
108.51%
Insiders
8.28%
Retail / Other
0.00%

Top Institutional Holders

  • OEP CAPITAL ADVISORS, L.P.
    16.31M12.23%
  • BlackRock Inc
    15.94M11.95%
  • Deerfield Management Co
    11.48M8.60%
  • SkyKnight Capital, L.P.
    8.58M6.43%
  • FMR Inc
    8.05M6.04%
  • Dimensional Fund Advisors, Inc.
    7.67M5.75%
  • Reinhart Mahoney Capital Management Inc
    7.42M5.56%
  • Vanguard Portfolio Management, LLC
    6.11M4.58%
  • Vanguard Capital Management, LLC
    4.50M3.37%
  • State Street Corp
    4.30M3.22%
  • Principal Financial Group Inc
    3.31M2.48%
  • Segall Bryant & Hamill
    3.22M2.41%
  • Geode Capital Management, LLC
    2.68M2.01%
  • Kennedy Capital Management Inc
    2.41M1.81%
  • Palisade Capital Management LLc
    2.16M1.62%

Top Fund Holders

  • iShares Core S&P Small-Cap ETF
    6.59M4.94%
  • Fidelity Value
    4.85M3.63%
  • Vanguard MStar Total Stk Mkt Idx Invest
    3.46M2.59%
  • iShares Russell 2000 ETF
    2.64M1.98%
  • Vanguard Small Cap Index
    2.50M1.87%